BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37604350)

  • 1. Cardiac miR-19a/19b was induced and hijacked by CVB3 to facilitate virus replication via targeting viral genomic RdRp-encoding region.
    Wu Y; Yue Y; Xiong S
    Antiviral Res; 2023 Sep; 217():105702. PubMed ID: 37604350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.
    Rani P; George B; V S; Biswas S; V M; Pal A; Rajmani RS; Das S
    J Virol; 2024 Feb; 98(2):e0150423. PubMed ID: 38289119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
    Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
    Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication
    Li J; Xie Y; Li L; Li X; Shen L; Gong J; Zhang R
    Front Immunol; 2020; 11():603437. PubMed ID: 33519812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148.
    Hemida MG; Ye X; Zhang HM; Hanson PJ; Liu Z; McManus BM; Yang D
    Cell Mol Life Sci; 2013 Jan; 70(2):277-91. PubMed ID: 22842794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence.
    Tong L; Lin L; Wu S; Guo Z; Wang T; Qin Y; Wang R; Zhong X; Wu X; Wang Y; Luan T; Wang Q; Li Y; Chen X; Zhang F; Zhao W; Zhong Z
    Nucleic Acids Res; 2013 Apr; 41(6):3760-71. PubMed ID: 23389951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization.
    Gou W; Zhang Z; Yang C; Li Y
    Exp Cell Res; 2018 May; 366(1):41-48. PubMed ID: 29524390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
    He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
    J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
    Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
    Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
    Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
    Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
    J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
    Liu H; Li M; Song Y; Xu W
    Front Immunol; 2018; 9():2479. PubMed ID: 30410495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
    Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
    Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
    Kraft L; Sauter M; Seebohm G; Klingel K
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection.
    Andréoletti L; Hober D; Becquart P; Belaich S; Copin MC; Lambert V; Wattré P
    J Med Virol; 1997 Jun; 52(2):206-14. PubMed ID: 9179770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis.
    He J; Yue Y; Dong C; Xiong S
    Clin Invest Med; 2013 Apr; 36(2):E103-11. PubMed ID: 23544605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.